Trial Profile
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Crossover Study Evaluating Efficacy of DFN-15 in Patients With Migraine Headache With or Without Aura
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2019
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 11 Jun 2017 Results of post hoc analysis evaluating variability of migraine symptoms (n=60), presented at the 59th Annual Scientific Meeting of the American Headache Society.
- 11 Jun 2017 Results (n=60) presented at the 59th Annual Scientific Meeting of the American Headache Society.
- 07 Jul 2016 Status changed from active, no longer recruiting to completed.